BioWorld Science

Jan. 26, 2007

View Archived Issues

MEK inhibitor potentiates dasatinib-induced apoptosis of CML cells

Read More

New therapeutic agents for cancer imparted in recent patents

Read More

Phase II study of MKC-1 in advanced breast cancer cleared to continue

Read More

Transtec provides reliable analgesia in cancer pain patients

Read More

Recent Uriach and ProMetic patents impart novel treatments for immune and autoimmune disorders

Read More

Recent Hammersmith Imanet patent discloses novel diagnostic agents

Read More

NNZ-2566 is safe in phase I study

Read More

Actemra demonstrates significant improvement in signs and symptoms of RA

Read More

Preclinical characterization of SSR-180711, a novel selective alpha7 nAChRr partial agonist

Read More

GlaxoSmithKline reports on melanocortin 4 receptor agonists as novel antiobesity compounds

Read More

Novel nonpeptide GLP-1 receptor agonist exhibits antidiabetic efficacy in vivo

Read More

Intranasal insulin improves memory

Read More

BioProgress updates drug development progress

Read More

New trial evaluates oral cladribine with Rebif for MS

Read More

Renovis announces restructuring plan

Read More

Cell Therapeutics makes unsolicited offer for DOR BioPharma

Read More

LX-1031 begins phase I trials for IBS and GI disorders

Read More

Molecular Insight acquires radiotherapy candidate Onalta

Read More

ADX-10061 begins proof-of-concept study for smoking cessation

Read More

Avontec and Activaero sign development deal for inhaleable AVT01

Read More

New phase II trial studies OBE-101 for weight loss in obese patients

Read More

Barrow receives grant to support neurofibromatosis research

Read More

Kirin and Astellas collaborate on anti-CD40 antagonistic MAb

Read More

Suboxone available in U.K.

Read More

Toyama seeks clearance to begin U.S. studies of T-705

Read More

Irinotecan eluting beads safe and effective in GI cancers

Read More